BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 374761)

  • 21. [An experimental study of the therapeutic effect of interleukin-2 and interleukin-12 with and without amphotericin B on pulmonary fungal infection].
    Zhang CR; Tang YC; Kawakami K; Zhang TT; Zhang KX; Zhu JX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):234-6. PubMed ID: 15144612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida lung abscess: successful treatment with amphotericin B and 5-flucytosine.
    Schiffman RL; Johnson TS; Weinberger SE; Weiss ST; Schwartz A
    Am Rev Respir Dis; 1982 Jun; 125(6):766-8. PubMed ID: 7091886
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of cerebral aspergillosis by stereotactic operation and antifungal therapy.
    Kerkmann ML; Blaschke-Hellmessen R; Mikulin HD
    Mycoses; 1994; 37(3-4):123-6. PubMed ID: 7845417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomal amphotericin-B as a therapeutic measure to control experimental aspergillosis in BALB/c mice.
    Ahmad I; Sarkar AK; Bachhawat BK
    Indian J Biochem Biophys; 1990 Dec; 27(6):370-4. PubMed ID: 2102483
    [No Abstract]   [Full Text] [Related]  

  • 25. [Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
    Kiyokawa H; Nakashima R; Takafuji S; Suzuki Y; Ito A
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):448-54. PubMed ID: 18592989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral pulmonary aspergilloma in ankylosing spondylitis treated with transthoracic intracavitary instillations of antifungal agents.
    Stiksa G; Eklundh G; Riebe I; Simonsson BG
    Scand J Respir Dis; 1976; 57(4):163-70. PubMed ID: 790560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal amphotericin B in three lung transplant recipients. The Groningen Lung Transplantation Group.
    Mannes GP; van der Bij W; de Boer WJ
    J Heart Lung Transplant; 1995; 14(4):781-4. PubMed ID: 7578189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of experimental invasive pulmonary aspergillosis in rats with liposomal amphotericin B].
    Matsuda H; Kohno S; Miyazaki Y; Mitsutake K; Tanaka K; Maesaki S; Iwamoto M; Hashimoto A; Kaku M; Koga H
    Kansenshogaku Zasshi; 1993 Feb; 67(2):102-9. PubMed ID: 8468494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation.
    Monteforte JS; Wood CA
    Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):112-4. PubMed ID: 8500477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemotherapy of aspergillus lung disease].
    Scholer HJ
    Mykosen; 1983 Apr; 26(4):173-96. PubMed ID: 6306462
    [No Abstract]   [Full Text] [Related]  

  • 33. Fungal pneumonia (Part 4): invasive pulmonary aspergillosis.
    Herbert PA; Bayer AS
    Chest; 1981 Aug; 80(2):220-5. PubMed ID: 6788456
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of Aspergillus niger pneumonia cured with an early diagnosis].
    Niki Y; Hashiguchi K; Tamada S; Yoshida K; Sugimura S; Nakajima M; Moriya O; Okimoto N; Soejima R
    Kansenshogaku Zasshi; 1994 Jun; 68(6):788-91. PubMed ID: 8051447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug therapy of intractable mycoses].
    Ikemoto H
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1680-4. PubMed ID: 2079591
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination therapy in a model of pulmonary aspergillosis.
    Schmitt HJ; Bernard EM; Edwards FF; Armstrong D
    Mycoses; 1991; 34(7-8):281-5. PubMed ID: 1803227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A non-immunosuppressed patient with presumably invasive pulmonary aspergillosis and a favourable outcome.
    Schrijver G; Verwers HR; Meinders AE
    Neth J Med; 1983; 26(4):112-9. PubMed ID: 6343901
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary cutaneous cryptococcosis successfully treated with outpatient amphotericin B and 5-fluorocytosine.
    Butler WP; Kaufer GI
    NITA; 1985; 8(4):295-7. PubMed ID: 3852083
    [No Abstract]   [Full Text] [Related]  

  • 39. [A cured case of primary pulmonary cryptococcosis with cryptococcal meningitis].
    Kitano M; Takeuchi Y; Matsui T; Asakura S; Fujio A; Aihara M
    Rinsho Kyobu Geka; 1985; 5(2):243-7. PubMed ID: 9423011
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycological-diagnostic assessment of the efficacy of amphotericin B + flucytosine to control Cryptococcus neoformans in AIDS patients.
    Staib F; Seibold M
    Mycoses; 1988 Apr; 31(4):175-86. PubMed ID: 3405247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.